Candidiasis, Invasive: all 65 studies

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN TrialNot yet recruitingNCT07788586Phase 4
• Invasive Candidiasis in Critical CareRecruitingNCT06456151
• Comparison of Uncomplicated Candidemia Therapy Duration in Children and AdultsRecruitingNCT05763251Not applicable
• A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.RecruitingNCT05421858Phase 3
• Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 4
• ECMM Candida Registry - CandiRegRecruitingNCT03450005
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral FluconazoleTerminatedNCT05178862Phase 3Results posted
• An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida AurisCompletedNCT04148287Phase 2Results posted
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 3Results posted
• Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)CompletedNCT03363841Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 3Results posted
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 2Results posted
• Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 2Results posted
• Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)TerminatedNCT01945281Phase 2Results posted
• Invasive Candidiasis in Saudi ICUsCompletedNCT01490684Results posted
• Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With EchinocandinsTerminatedNCT01213823Results posted
• A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)CompletedNCT01165320Phase 2Results posted
• Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)TerminatedNCT01045798Phase 2Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 3Results posted
• Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 3Results posted
• Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
• β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNCT00672841Not applicableResults posted
• This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
• Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)CompletedNCT00520234Phase 4Results posted
• Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 3Results posted
• A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)CompletedNCT00250432Phase 3Results posted
• Phylogenetic Characteristics of Different Candida Species and Their Impact on the Clinical Picture of Patients With Invasive Candidiasis. What Has Changed During the COVID Pandemic?WithdrawnNCT07422194
• Non-Conventional Microbiological Methods in the Diagnosis of CandidemiaCompletedNCT07422155Not applicable
• A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT06194201Phase 2
• Clinical Study to Evaluate the Efficacy of an Anti-Fungal SupplementCompletedNCT06146504Not applicable
• Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection.CompletedNCT05848492Phase 3
• A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 3
• Evaluate Bioequivalence of Micafungin (50mg/Vial)CompletedNCT05496725Phase 4
• Early Identification of Candida in Intra-abdominal CandidiasisCompletedNCT05264571
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
• Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive AspergillosisStatus unknownNCT04225195Phase 2
• Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2)CompletedNCT03997929
• Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With MicafunginTerminatedNCT03906916Phase 4
• Early Discontinuation of Empirical Antifungal Therapy and BiomarkersCompletedNCT03538912Not applicable
• Influence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (BDG) ValuesCompletedNCT03468803Not applicable
• Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida MeningitisCompletedNCT03421002Phase 2
• Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT03174457
• A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive CandidiasisTerminatedNCT03090334Not applicable
• Genetic Susceptibility Factors for Candidemia.CompletedNCT02841501
• NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida SepsisCompletedNCT02801682
• Variability of Fluconazole Concentration in Critically Ill PatientsCompletedNCT02491151
• Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.CompletedNCT02333448
• BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric CandidemiaCompletedNCT02220790
• Pharmacokinetics of Micafungin in Patients of Intensive Care UnitsCompletedNCT02164890Phase 4
• Empirical Antifungal Treatment in ICUSCompletedNCT01773876Phase 3
• Pharmacokinetics of Micafungin in Critically Ill PatientsCompletedNCT01716988
• Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane OxygenationCompletedNCT01666769Phase 1
• Anidulafungin Pharmacokinetics in Intensive Care Unit PatientsStatus unknownNCT01438216
• Anidulafungin in Patients With Hematologic MalignanciesTerminatedNCT01053884Phase 2
• Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)CompletedNCT01047267
• Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?CompletedNCT00786903
• CRITIC - Treatment of Candidemia and Invasive CandidiasisCompletedNCT00670657Phase 4
• Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
• Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
• Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal InfectionCompletedNCT00388167
• Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
• The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
• The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2

← Candidiasis, Invasive overview